Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents of QLY Biotech Group Corp. from 31 Aug 2020 to 28 Feb 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.
Summary
QLY Biotech Group Corp. quarterly Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents in USD history and change rate from 31 Aug 2020 to 28 Feb 2023.
  • QLY Biotech Group Corp. Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents for the quarter ending 28 Feb 2023 was $0, a 100% decline year-over-year.
Source SEC data
View on sec.gov
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Quarterly (USD)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, YoY Quarterly Change (%)

QLY Biotech Group Corp. Quarterly Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q1 2023 $0 -$1,123 -100% 28 Feb 2023 10-Q 13 Apr 2023 2023 Q2
Q4 2022 $0 -$1,160 -100% 30 Nov 2022 10-Q 13 Jan 2023 2023 Q1
Q3 2022 $0 -$5,169 -100% 31 Aug 2022 10-Q 13 Apr 2023 2023 Q2
Q1 2022 $1,123 28 Feb 2022 10-Q 13 Apr 2023 2023 Q2
Q4 2021 $1,160 30 Nov 2021 10-Q 13 Jan 2023 2023 Q1
Q3 2021 $5,169 -$22,465 -81% 31 Aug 2021 10-Q 13 Apr 2023 2023 Q2
Q3 2020 $27,634 31 Aug 2020 10-K 14 Dec 2022 2022 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.